ESR1 and neoplasm: Tamoxifen (TAM) is a classic drug for endocrine therapy of breast cancer, especially for estrogen receptor (ER) positive patients with better effect and longer duration, which can significantly reduce the recurrence rate and mortality of tumor [5].